Skip to main content
AAN.com
Research Article
April 19, 2023
editorial

Association of Neighborhood Deprivation With Cognitive and Mood Outcomes in Adults With Pharmacoresistant Temporal Lobe Epilepsy

June 6, 2023 issue
100 (23) e2350-e2359

Abstract

Background and Objectives

Temporal lobe epilepsy (TLE) is the most common adult form of epilepsy and is associated with a high risk of cognitive deficits and depressed mood. However, little is known about the role of environmental factors on cognition and mood in TLE. This cross-sectional study examined the relationship between neighborhood deprivation and neuropsychological function in adults with TLE.

Methods

Neuropsychological data were obtained from a clinical registry of patients with TLE and included measures of intelligence, attention, processing speed, language, executive function, visuospatial skills, verbal/visual memory, depression, and anxiety. Home addresses were used to calculate the Area Deprivation Index (ADI) for each individual, which were separated into quintiles (i.e., quintile 1 = least disadvantaged and quintile 5 = most disadvantaged). Kruskal-Wallis tests compared quintile groups on cognitive domain scores and mood and anxiety scores. Multivariable regression models, with and without ADI, were estimated for overall cognitive phenotype and for mood and anxiety scores.

Results

A total of 800 patients (median age 38 years; 58% female) met all inclusion criteria. Effects of disadvantage (increasing ADI) were observed across nearly all measured cognitive domains and with significant increases in symptoms of depression and anxiety. Furthermore, patients in more disadvantaged ADI quintiles had increased odds of a worse cognitive phenotype (p = 0.013). Patients who self-identified as members of minoritized groups were overrepresented in the most disadvantaged ADI quintiles and were 2.91 (95% CI 1.87–4.54) times more likely to be in a severe cognitive phenotype than non-Hispanic White individuals (p < 0.001). However, accounting for ADI attenuated this relationship, suggesting neighborhood deprivation may account for some of the relationship between race/ethnicity and cognitive phenotype (ADI-adjusted proportional odds ratio 1.82, 95% CI 1.37–2.42).

Discussion

These findings highlight the importance of environmental factors and regional characteristics in neuropsychological studies of epilepsy. There are many potential mechanisms by which neighborhood disadvantage can adversely affect cognition (e.g., fewer educational opportunities, limited access to health care, food insecurity/poor nutrition, and greater medical comorbidities). Future research will seek to investigate these potential mechanisms and determine whether structural and functional alterations in the brain moderate the relationship between ADI and cognition.

Get full access to this article

View all available purchase options and get full access to this article.

References

1.
Oyegbile TO, Dow C, Jones J, et al. The nature and course of neuropsychological morbidity in chronic temporal lobe epilepsy. Neurology. 2004;62(10):1736-1742.
2.
Zhao F, Kang H, You L, Rastogi P, Venkatesh D, Chandra M. Neuropsychological deficits in temporal lobe epilepsy: a comprehensive review. Ann Indian Acad Neurol. 2014;17(4):374-382.
3.
Gilliam FG, Santos J, Vahle V, Carter J, Brown K, Hecimovic H. Depression in epilepsy: ignoring clinical expression of neuronal network dysfunction? Epilepsia. 2004;45(suppl 2):28-33.
4.
Tsopelas ND, Saintfort R, Fricchione GL. The relationship of psychiatric illnesses and seizures. Curr Psychiatry Rep. 2001;3:235-242.
5.
Giovagnoli AR, Parente A, Tarallo A, Casazza M, Franceschetti S, Avanzini G. Self-rated and assessed cognitive functions in epilepsy: impact on quality of life. Epilepsy Res. 2014;108(8):1461-1468.
6.
McAuley JW, Elliott JO, Patankar S, et al. Comparing patients' and practitioners' views on epilepsy concerns: a call to address memory concerns. Epilepsy Behav. 2010;19(4):580-583.
7.
Hermann BP, Struck AF, Busch RM, Reyes A, Kaestner E, McDonald CR. Neurobehavioural comorbidities of epilepsy: towards a network-based precision taxonomy. Nat Rev Neurol. 2021;17(12):731-746.
8.
Pickrell WO, Lacey AS, Bodger OG, et al. Epilepsy and deprivation, a data linkage study. Epilepsia. 2015;56(4):585-591.
9.
Symonds JD, Elliott KS, Shetty J, et al. Early childhood epilepsies: epidemiology, classification, aetiology, and socio-economic determinants. Brain. 2021;144(9):2879-2891.
10.
Maloney EM, Corcoran P, Costello DJ, O'Reilly ÉJ. Association between social deprivation and incidence of first seizures and epilepsy: a prospective population-based cohort. Epilepsia. 2022;63(8):2108-2119.
11.
Kobau R, Zahran H, Thurman DJ, et al. Epilepsy surveillance among adults: 19 states, behavioral risk factor surveillance system, 2005. MMWR Surveill Summ. 2008;57(6):1-20.
12.
Link B, Phelan J. Social conditions as fundamental causes of health inequalities. In: Handbook of Medical Sociology, Vol 3-17. Vanderbilt University Press; 2010.
13.
Rosendale N. Social determinants of health in neurology. Neurol Clin. 2022;40(1):231-247.
14.
Burneo JG, Jette N, Theodore W, et al. Disparities in epilepsy: report of a systematic review by the North American Commission of the International League Against Epilepsy. Epilepsia. 2009;50(10):2285-2295.
15.
Nathan CL, Gutierrez C. FACETS of health disparities in epilepsy surgery and gaps that need to be addressed. Neurol Clin Pract. 2018;8(4):340-345.
16.
Tian N, Kobau R, Zack MM, Greenlund KJ. Barriers to and disparities in access to health care among adults aged ≥18 years with epilepsy: United States, 2015 and 2017. MMWR Morb Mortal Wkly Rep. 2022;71(21):697-702.
17.
Bailey ZD, Krieger N, Agénor M, Graves J, Linos N, Bassett MT. Structural racism and health inequities in the USA: evidence and interventions. Lancet. 2017;389(10077):1453-1463.
18.
Vargas T, Damme KSF, Mittal VA. Neighborhood deprivation, prefrontal morphology and neurocognition in late childhood to early adolescence. Neuroimage. 2020;220:117086.
19.
Hunt JFV, Vogt NM, Jonaitis EM, et al. Association of neighborhood context, cognitive decline, and cortical change in an unimpaired cohort. Neurology. 2021;96(20):e2500-e2512.
20.
Richardson R, Westley T, Gariépy G, Austin N, Nandi A. Neighborhood socioeconomic conditions and depression: a systematic review and meta-analysis. Soc Psychiatry Psychiatr Epidemiol. 2015;50(11):1641-1656.
21.
Botdorf M, Dunstan J, Sorcher L, Dougherty LR, Riggins T. Socioeconomic disadvantage and episodic memory ability in the ABCD sample: contributions of hippocampal subregion and subfield volumes. Dev Cogn Neurosci. 2022;57:101138.
22.
Vassilaki M, Aakre JA, Castillo A, et al. Association of neighborhood socioeconomic disadvantage and cognitive impairment. Alzheimers Dement. 2022;19(3):761-770.
23.
Szaflarski M. Social determinants of health in epilepsy. Epilepsy Behav. 2014;41:283-289.
24.
Gordon KE, Dooley JM. Food insecurity and epilepsy in a nationally representative sample. Epilepsy Behav. 2015;43:139-142.
25.
Fiest KM, Birbeck GL, Jacoby A, Jette N. Stigma in epilepsy. Curr Neurol Neurosci Rep. 2014;14(5):444.
26.
Baxendale S, Heaney D. Socioeconomic status, cognition, and hippocampal sclerosis. Epilepsy Behav. 2011;20(1):64-67.
27.
Carson J, Weir A, Chin RF, McLellan A. Socioeconomic deprivation is an independent risk factor for behavioral problems in children with epilepsy. Epilepsy Behav. 2015;45:105-109.
28.
Hohmann L, Holtkamp M, Oltmanns F, Bengner T. Associations of individual and structural socioeconomic status with cognition and mental distress in pharmacoresistant focal epilepsy. Epilepsy Behav. 2021;116:107726.
29.
Singh GK. Area deprivation and widening inequalities in US mortality, 1969-1998. Am J Public Health. 2003;93(7):1137-1143.
30.
Kind AJH, Buckingham WR. Making neighborhood-disadvantage metrics accessible: the neighborhood atlas. N Engl J Med. 2018;378(26):2456-2458.
31.
Hermann B, Seidenberg M, Lee EJ, Chan F, Rutecki P. Cognitive phenotypes in temporal lobe epilepsy. J Int Neuropsychol Soc. 2007;13(1):12-20.
32.
Hermann BP, Struck AF, Dabbs K, Seidenberg M, Jones JE. Behavioral phenotypes of temporal lobe epilepsy. Epilepsia Open. 2021;6(2):369-380.
33.
Hermann BP, Struck AF, Stafstrom CE, et al. Behavioral phenotypes of childhood idiopathic epilepsies. Epilepsia. 2020;61(7):1427-1437.
34.
Hermann B, Conant LL, Cook CJ, et al. Network, clinical and sociodemographic features of cognitive phenotypes in temporal lobe epilepsy. Neuroimage Clin. 2020;27:102341.
35.
Norman M, Wilson SJ, Baxendale S, et al. Addressing neuropsychological diagnostics in adults with epilepsy: introducing the International Classification of Cognitive Disorders in Epilepsy: the IC CODE Initiative. Epilepsia Open. 2021;6(2):266-275.
36.
McDonald CR, Busch RM, Reyes A, et al. Development and application of the International Classification of Cognitive Disorders in Epilepsy (IC-CoDE): initial results from a multi-center study of adults with temporal lobe epilepsy. Neuropsychology. 2023;37(3):301-314.
37.
RStudio Team. RStudio: Integrated Development for R. RStudio, Inc.; 2015.
38.
Westreich D, Greenland S. The table 2 fallacy: presenting and interpreting confounder and modifier coefficients. Am J Epidemiol. 2013;177(4):292-298.
39.
Vassilaki M, Petersen RC, Vemuri P. Area deprivation index as a surrogate of resilience in aging and dementia. Front Psychol. 2022;13:930415.
40.
Hunt JFV, Buckingham W, Kim AJ, et al. Association of neighborhood-level disadvantage with cerebral and hippocampal volume. JAMA Neurol. 2020;77(4):451-460.
41.
Ioannou P, Foster DL, Sander JW, et al. The burden of epilepsy and unmet need in people with focal seizures. Brain Behav. 2022;12(9):e2589.
42.
Szaflarski M. Racialized inequities in epilepsy burden and treatment. Neurol Clin. 2022;40(4):821-830.
43.
Webb EK, Weis CN, Huggins AA, et al. Neighborhood disadvantage is associated with stable deficits in neurocognitive functioning in traumatically-injured adults. Health Place. 2021;67:102493.
44.
Kind AJH, Jencks S, Brock J, et al. Neighborhood socioeconomic disadvantage and 30-day rehospitalization: a retrospective cohort study. Ann Intern Med. 2014;161(11):765.
45.
Pedraza O, Mungas D. Measurement in cross-cultural neuropsychology. Neuropsychol Rev. 2008;18(3):184-193.
46.
Rivera Mindt M, Byrd D, Saez P, Manly J. Increasing culturally competent neuropsychological services for ethnic minority populations: a call to action. Clin Neuropsychol. 2010;24(3):429-453.
47.
Moore TM, Martin IK, Gur OM, et al. Characterizing social environment's association with neurocognition using census and crime data linked to the Philadelphia Neurodevelopmental Cohort. Psychol Med. 2016;46(3):599-610.
48.
Bygrave DC, Gerassimakis CS, Mwendwa DT, Erus G, Davatzikos C, Wright RS. The role of race in relations of social support to hippocampal volumes among older adults. Res Aging. 2022;44(2):205-214.
49.
Sims RC, Levy SA, Mwendwa DT, Callender CO, Campbell AL. The influence of functional social support on executive functioning in middle-aged African Americans. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2011;18(4):414-431.
50.
Bensken WP, Krieger NI, Berg KA, Einstadter D, Dalton JE, Perzynski AT. Health status and chronic disease burden of the homeless population: an analysis of two decades of multi-institutional electronic medical records. J Health Care Poor Underserved. 2021;32(3):1619-1634.

Information & Authors

Information

Published In

Neurology®
Volume 100Number 23June 6, 2023
Pages: e2350-e2359
PubMed: 37076308

Publication History

Received: September 22, 2022
Accepted: February 21, 2023
Published online: April 19, 2023
Published in issue: June 6, 2023

Permissions

Request permissions for this article.

Disclosure

R.M. Busch receives support from the National Institute of Neurological Disorders and Stroke (NINDS) (R01NS120976, R01NS035140, R01NS097719, and R61AG069729). J.E. Dalton receives support from the NIA (R01G055480 and R01AG059979) and NHLBI (R01HL153175). L. Jehi receives support from NINDS (R01NS097719) and NCATS (UL1TR002548). L. Ferguson receives support from the NINDS (R01NS120976, R01NS035140, and R01NS109493). A.F. Struck receives funding from Ceribell. A.F. Struck and B.P. Hermann are supported by the NINDS (R01NS111022, R01NS120976, R01NS117568). None of these grants are directly related to the project reported in this manuscript. Go to Neurology.org/N for full disclosures.

Study Funding

Primary support for this study was provided by the Cleveland Clinic Epilepsy Center.

Authors

Affiliations & Disclosures

From the Epilepsy Center (R.M.B., L.J., L.F.), Department of Neurology (R.M.B., L.J.), Neurological Institute, Department of Quantitative Health Sciences (J.E.D., N.I.K.), and Center for Computational Life Sciences (L.J.), Lerner Research Institute, Cleveland Clinic, OH; and Department of Neurology (A.F.S., B.P.H.), University of Wisconsin School of Medicine and Public Health, Madison.
Disclosure
Scientific Advisory Boards:
1.
None
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
Honorarium for speaking at American Epilepsy Society Annual Meeting
Editorial Boards:
1.
Epilepsy & Behavior, Associate Editor, 2019-present Epilepsy & Behavior, Editorial Board Member, 2014-presentEpilepsy & Behavior Case Reports, Editorial BoardMember, 2014-presentNeuropsychology Review, Associated Editor, 2021-present
Patents:
1.
Patent applicant pending for an automated cognitive screening tool.
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
Dr. Busch receives institutional support for epilepsy research from the Cleveland Clinic Epilepsy Center.
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
National Institutes of Health / National Institute of Neurological Disorders and Stroke (NIH/NINDS), R01NS120976, R61AG069729, R33AG069729, R01NS097719, R01NS035140, U54NS092090
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
None
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
Ceraxis Health Inc, rights to future revenues or distributions as an inventor.
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Jarrod E. Dalton, PhD*
From the Epilepsy Center (R.M.B., L.J., L.F.), Department of Neurology (R.M.B., L.J.), Neurological Institute, Department of Quantitative Health Sciences (J.E.D., N.I.K.), and Center for Computational Life Sciences (L.J.), Lerner Research Institute, Cleveland Clinic, OH; and Department of Neurology (A.F.S., B.P.H.), University of Wisconsin School of Medicine and Public Health, Madison.
Disclosure
Scientific Advisory Boards:
1.
None
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
None
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
Cleveland Clinic, multiple positions, 16 years
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
Sponsor Agency and ID # National Institute on Aging (R01AG080486)Title of Grant Digital Twin Neighborhoods for Research on Place-Based Health Inequalities in Mid-LifeRole Principal InvestigatorStart-End Dates2023 &#x0096; 2027Sponsor Agency and ID # National Heart. Lung and Blood Institute (R01HL153175)Title of Grant Forecasting Lung Transplant Benefit: A Dynamic Risk Modeling Approach Role Principal InvestigatorStart-End Dates 2020 &#x0096; 2024Sponsor Agency and ID # National Institute on Aging (R01AG055480)Title of Grant Modeling and Forecasting Atherosclerotic Risk: A Complex SystemsApproachRole Principal InvestigatorStart-End Dates2017 &#x0096; 2022Sponsor Agency and ID # National Institute on Aging (3R01AG055480-04S2)Title of Grant Mechanisms of Cognitive Decline Across Socioeconomic and Clinical ContextsRole Principal InvestigatorStart-End Dates 2020 &#x0096; 2022Sponsor Agency and ID # National Institute on Aging (3R01AG055480-04S1)Title of Grant Cardiovascular Risk among Transgender Persons in a Regional Electronic Health Record RegistryRole Principal InvestigatorStart-End Dates 2020 &#x0096; 2022Sponsor Agency and ID # National Institute on Aging (R01AG059979)Title of Grant Testing the Effectiveness of Individualized Disease Prevention for Middle-Aged AdultsRole Co-InvestigatorStart-End Dates 2019 &#x0096; 2024
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
None
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
From the Epilepsy Center (R.M.B., L.J., L.F.), Department of Neurology (R.M.B., L.J.), Neurological Institute, Department of Quantitative Health Sciences (J.E.D., N.I.K.), and Center for Computational Life Sciences (L.J.), Lerner Research Institute, Cleveland Clinic, OH; and Department of Neurology (A.F.S., B.P.H.), University of Wisconsin School of Medicine and Public Health, Madison.
Disclosure
Scientific Advisory Boards:
1.
None
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
None
Editorial Boards:
1.
Epilepsia Open- Associate Editor 2016-Epilepsy Currents- Senior clinical editor 2019-
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NCATS, NINDS
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
None
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Lisa Ferguson, MA
From the Epilepsy Center (R.M.B., L.J., L.F.), Department of Neurology (R.M.B., L.J.), Neurological Institute, Department of Quantitative Health Sciences (J.E.D., N.I.K.), and Center for Computational Life Sciences (L.J.), Lerner Research Institute, Cleveland Clinic, OH; and Department of Neurology (A.F.S., B.P.H.), University of Wisconsin School of Medicine and Public Health, Madison.
Disclosure
Scientific Advisory Boards:
1.
None
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
None
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
None
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Nikolas I. Krieger, MS
From the Epilepsy Center (R.M.B., L.J., L.F.), Department of Neurology (R.M.B., L.J.), Neurological Institute, Department of Quantitative Health Sciences (J.E.D., N.I.K.), and Center for Computational Life Sciences (L.J.), Lerner Research Institute, Cleveland Clinic, OH; and Department of Neurology (A.F.S., B.P.H.), University of Wisconsin School of Medicine and Public Health, Madison.
Disclosure
Scientific Advisory Boards:
1.
None
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
None
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
Cleveland Clinic Foundation, Data scientist, August 2018 - October 2020Cleveland Clinic Foundation, Senior Notification PRN, October 2020 - present
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
None
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Aaron F. Struck, MD
From the Epilepsy Center (R.M.B., L.J., L.F.), Department of Neurology (R.M.B., L.J.), Neurological Institute, Department of Quantitative Health Sciences (J.E.D., N.I.K.), and Center for Computational Life Sciences (L.J.), Lerner Research Institute, Cleveland Clinic, OH; and Department of Neurology (A.F.S., B.P.H.), University of Wisconsin School of Medicine and Public Health, Madison.
Disclosure
Scientific Advisory Boards:
1.
None
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
None
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
(1) Ceribell, received research support.
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
None
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
From the Epilepsy Center (R.M.B., L.J., L.F.), Department of Neurology (R.M.B., L.J.), Neurological Institute, Department of Quantitative Health Sciences (J.E.D., N.I.K.), and Center for Computational Life Sciences (L.J.), Lerner Research Institute, Cleveland Clinic, OH; and Department of Neurology (A.F.S., B.P.H.), University of Wisconsin School of Medicine and Public Health, Madison.
Disclosure
Scientific Advisory Boards:
1.
Member of DSMB for Medtronics (Slate Study)
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
None
Editorial Boards:
1.
Journal of the International Neuropsychological Society,Editorial Board, 2015--present.
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NIH R01 NS120976 NIH R01 NS111022 NIH R01 NS117568 NIH R01 AG027161 NIH R01 NS123378
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
None
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE

Notes

Correspondence Dr. Busch [email protected]
Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.
Disclaimer: The views expressed in this article do not necessarily represent the views of the US Department of Agriculture, its Office of the Inspector General, or the United States.
Submitted and externally peer reviewed. The handling editor was Associate Editor Barbara Jobst, MD, PhD, FAAN.
*
These authors contributed equally to this work as first authors.

Metrics & Citations

Metrics

Citation information is sourced from Crossref Cited-by service.

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Cognitive and brain health in juvenile myoclonic epilepsy: Role of social determinants of health, Epilepsia, (2025).https://doi.org/10.1111/epi.18296
    Crossref
  2. Evaluation of social deprivation as a modifier of phenotypic divergence in PTEN Hamartoma Tumor Syndrome, Rare, 3, (100053), (2025).https://doi.org/10.1016/j.rare.2024.100053
    Crossref
  3. Differential associations of neighborhood disadvantage, race/ethnicity, and cognitive status with experiences of psychosocial distress in the HABS‐HD cohort, Alzheimer's & Dementia, 21, 1, (2024).https://doi.org/10.1002/alz.14257
    Crossref
  4. Evaluating Social Determinants of Health–Based Alternatives to Race-Based Cognitive Normative Models, Neurology, 103, 11, (2024)./doi/10.1212/WNL.0000000000210030
    Abstract
  5. Exploring Health Inequalities and Presurgical Attitudes on Postsurgical Outcomes in Spine Surgery, World Neurosurgery, 190, (e648-e664), (2024).https://doi.org/10.1016/j.wneu.2024.07.198
    Crossref
  6. Individual- and community-level social determinants of health are associated with cognition in older adults with focal epilepsy, Epilepsy & Behavior, 158, (109927), (2024).https://doi.org/10.1016/j.yebeh.2024.109927
    Crossref
  7. A user's guide for the International Classification of Cognitive Disorders in Epilepsy, Epileptic Disorders, 26, 5, (567-580), (2024).https://doi.org/10.1002/epd2.20268
    Crossref
  8. The relevance of Spearman's g for epilepsy , Brain Communications, 6, 3, (2024).https://doi.org/10.1093/braincomms/fcae176
    Crossref
  9. Polygenic burden and its association with baseline cognitive function and postoperative cognitive outcome in temporal lobe epilepsy, Epilepsy & Behavior, 153, (109692), (2024).https://doi.org/10.1016/j.yebeh.2024.109692
    Crossref
  10. Hiding in Plain Sight—Neighborhood Versus Individual Determinants of Psychological Outcomes in Patients With Epilepsy, Epilepsy Currents, 24, 2, (102-104), (2024).https://doi.org/10.1177/15357597231223588
    Crossref
  11. See more
Loading...

View Options

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.

If you need immediate support or to place an order, please call or email customer service:

  • 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
  • 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
  • [email protected]

We appreciate your patience during this time and apologize for any inconvenience.

View options

PDF and All Supplements

Download PDF and Supplementary Material

Short Form

Short Form

Full Text

View Full Text

Full Text HTML

View Full Text HTML

Figures

Tables

Media

Share

Share

Share article link

Share